Spanning Science and Clinic | GenomeWeb

Spanning Science and Clinic

Premium

From his perch as scientific director of the Harvard Partners Center for Genetics and Genomics, Raju Kucherlapati has a bird’s eye view of how translational research is rolling out in academic medical centers. Genome Technology caught up with him to find out how the meeting of the basic science and clinical worlds is going.

Genome Technology: Where in the clinic will genomics have the first impact? Why?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.